Kelyniam Global Inc. Reports Settlement of Lawsuit
05 Novembro 2013 - 10:13AM
Kelyniam Global Inc. (OTC: KLYG) has successfully resolved the
lawsuit with former employee John Mastoloni. Per terms of the
settlement agreement, details are confidential. President
& CEO Tennyson Anthony stated, "While we cannot disclose
details, shareholders should be pleased to know that the matter was
resolved for only a fraction of the amount the company had set
aside."
As mentioned in the most recent earnings release, Kelyniam will
be announcing a new product, expected within the next 2 months.
A bout Kelyniam Global,
Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use
of CAD/CAM technology to provide patient specific custom implants
to assist medical professionals by allowing them to operate more
effectively, improve patient care, and reduce health care costs by
providing the highest quality products available with today's
technology. The company is continually researching and developing
new products and processes to help patients live more active and
productive lives.
Please visit our website at www.kelyniam.com for more
information.
Forward-Looking Statements
Except for historical information contained in this release, the
matters discussed are forward-looking statements that involve risks
and uncertainties. When used in this release, words such as
"anticipate," "believes," "estimate," "expect," "should," "intend,"
"projects," "objective" and "appears" and similar expressions, as
they relate to the Company or its management, identify
forward-looking statements. Such forward-looking statements are
based on the beliefs of the Company's management, as well as
assumptions made by and information currently available to the
Company's management. Among the factors that could cause actual
results to differ materially are the following: the effect of
business and economic conditions; the impact of competitive
products and pricing; capacity and supply constraints or
difficulties; product development, commercialization or
technological difficulties; the regulatory and trade environment;
the impact of reimbursement rates and coverage; and the risk
factors reported from time to time in the Company's SEC reports.
The Company undertakes no obligation to revise any forward-looking
statements as a result of future events or developments.
Kelyniam Global (PK) (USOTC:KLYG)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Kelyniam Global (PK) (USOTC:KLYG)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Kelyniam Global Inc (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de